Persistent immune abnormalities discriminate post-COVID syndrome from convalescence
Julia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, Veronica Ober, Eva Grüner, Claire Pleimelding, Leonard Gilberg, Isabel Brand, Nikolas Weigl, Mohamed I. M. Ahmed, Gerardo Ibarra, Michael Ruzicka, Christopher Benesch, Anna Pernpruner, Elisabeth Valdinoci, Michael Hoelscher, Kristina Adorjan, Hans Christian Stubbe, Michael Pritsch, Ulrich Seybold, Johannes Bogner, Julia Roider the Post Covid Care and KoCo19 study groups
doi: https://doi.org/10.1101/2023.05.02.23289345
Julia Sbierski-Kind
1Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
2Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
Stephan Schlickeiser
3Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Institute of Medical Immunology, Augustenburger Platz 1, 13353 Berlin, Germany
4Berlin Institute of Health (BIH) at Charité - Universitätsmedizin Berlin, BIH Center for Regenerative Therapies (BCRT), Charitéplatz 1, 10117 Berlin, Germany
Svenja Feldmann
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Veronica Ober
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Eva Grüner
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Claire Pleimelding
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Leonard Gilberg
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Isabel Brand
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
Nikolas Weigl
7Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Mohamed I. M. Ahmed
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
8Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Gerardo Ibarra
2Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital, Eberhard-Karls-Universität Tübingen, Tübingen, Germany
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Michael Ruzicka
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
10Department of Medicine III, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Christopher Benesch
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
11Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Anna Pernpruner
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
11Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Elisabeth Valdinoci
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
11Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Michael Hoelscher
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
8Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Kristina Adorjan
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
12Department of Psychiatry and Psychotherapy, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Hans Christian Stubbe
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
9COVID-19 Registry of the LMU Munich (CORKUM), University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
11Department of Medicine II, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Michael Pritsch
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
8Division of Infectious Diseases and Tropical Medicine, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Ulrich Seybold
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
Johannes Bogner
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
Julia Roider
5Department of Infectious Diseases, Department of Medicine IV, University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany
6German Center for Infection Research (DZIF), Partner Site Munich, Munich, Germany
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted May 05, 2023.
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence
Julia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, Veronica Ober, Eva Grüner, Claire Pleimelding, Leonard Gilberg, Isabel Brand, Nikolas Weigl, Mohamed I. M. Ahmed, Gerardo Ibarra, Michael Ruzicka, Christopher Benesch, Anna Pernpruner, Elisabeth Valdinoci, Michael Hoelscher, Kristina Adorjan, Hans Christian Stubbe, Michael Pritsch, Ulrich Seybold, Johannes Bogner, Julia Roider
medRxiv 2023.05.02.23289345; doi: https://doi.org/10.1101/2023.05.02.23289345
Persistent immune abnormalities discriminate post-COVID syndrome from convalescence
Julia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, Veronica Ober, Eva Grüner, Claire Pleimelding, Leonard Gilberg, Isabel Brand, Nikolas Weigl, Mohamed I. M. Ahmed, Gerardo Ibarra, Michael Ruzicka, Christopher Benesch, Anna Pernpruner, Elisabeth Valdinoci, Michael Hoelscher, Kristina Adorjan, Hans Christian Stubbe, Michael Pritsch, Ulrich Seybold, Johannes Bogner, Julia Roider
medRxiv 2023.05.02.23289345; doi: https://doi.org/10.1101/2023.05.02.23289345
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)